Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application - Overview of Currently Available Psychiatric Drugs, Covering More Than 250 Different Compounds.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c53029) has announced the addition of Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application to their offering.

Antidepressants and related psychiatric drugs are the most important prescription drugs worldwide, accounting for a market volume of 20 billion US$ per year. This handbook provides a complete and detailed overview of all currently available psychiatric drugs, covering more than 250 different compounds.

Particular features include:

- The most important information on the chemistry, pharmacology and therapeutic use of a given drug

- A special layout with margin notes and compound structures allowing for quick and easy access to the desired information

Written by drug developers from the pharmaceutical industry, novel drugs currently under development and new methods of treatment are listed side by side with classical drugs, allowing a direct comparison of traditional and innovative therapeutic approaches.

Author information

The editors all work for the Spanish-based pharmaceutical company Esteve, a world leader in neuropharmaceuticals.

Helmut Buschmann is the research director of Esteve, in charge of the discovery and development of new active substances for a variety of neurological disorders. He was formerly the head of research at Gruenenthal, a Germany-based pharma company that also specialized in neuropharmaceuticals. During his time at Gruenenthal, he published a widely acclaimed book on analgesics that pioneered the integrated approach followed also in his most recent book.

Content Outline:

VOL VOL Volume
VOL Volunteer
VOL Volcano
VOL Volvo (stock symbol)
VOL Verdingungsordnung für Leistungen (German)
VOL Volatile Organic Liquid
Vol Volscan (linguistics) 
. 1

DEPRESSIVE DISORDERS

Neurobiology Neurobiology

Study of the development and function of the nervous system, with emphasis on how nerve cells generate and control behavior. The major goal of neurobiology is to explain at the molecular level how nerve cells differentiate and develop their
 of Mood Disorders

Clinical Aspects of Depressive Disorders

Pharmacotherapy of Depression

Modeling Human Depression by Animal Models

Marketed Drugs and Drugs in Development

- summary of drug classes

- tricyclic tricyclic /tri·cyc·lic/ (-sik´lik) containing three fused rings or closed chains in the molecular structure; see also under antidepressant.

tricyclic

containing three fused rings in the molecular structure.
 and tetracyclic antidepressants

- serotonergic se·ro·to·ner·gic or se·ro·to·ni·ner·gic
adj.
Activated by or capable of liberating serotonin, especially in transmitting nerve impulses.



serotonergic

containing or activated by serotonin.
 agents

- noradrenaline noradrenaline /nor·adren·a·line/ (nor?ah-dren´ah-lin) norepinephrine.
noradrenaline (nōrˈ·
 reuptake reuptake /re·up·take/ (re-up´tak) reabsorption of a previously secreted substance.

re·up·take
n.
 inhibitors

- monoamine oxidase inhibitors Monoamine Oxidase Inhibitors Definition

Monoamine oxidase inhibitors (MAO inhibitors) are medicines that relieve certain types of mental depression.
 

- miscellaneous agents

- compounds launched in single countries

- new opportunities for marketed drugs

- antidepressants in development

SCHIZOPHRENIA AND OTHER PSYCHOSES

Current Status and Challenges in Schizophrenia Research

Schizophrenia: A Clinical Review

Pharmacotherapy of Schizophrenia

Modeling Schizophrenia in Experimental Animals

Marketed Drugs and Drugs in Development

- summary of drug classes

- typical antipsychotics

- atypical antipsychotics

- drugs in development

VOL. 2

ANXIETY

Introductory and Basic Aspects

Clinical Aspects of Anxiety

Pharmacology of Anxiety

Modeling Human Anxiety by Animal Models

Marketed Drugs and Drugs in Development

- summary of drug classes

- benzodiazepines Benzodiazepines Definition

Benzodiazepines are medicines that help relieve nervousness, tension, and other symptoms by slowing the central nervous system.
Purpose

Benzodiazepines are a type of antianxiety drugs.
 

- serotonergic drugs

- GABAergic agents

- dopaminergic dopaminergic /do·pa·min·er·gic/ (do?pah-men-er´jik) activated or transmitted by dopamine; pertaining to tissues or organs affected by dopamine.

do·pa·mi·ner·gic
adj.
 agents

- serotonin reuptake inhibitors

- 5-HT2 receptor antagonists

- beta-adrenoceptor antagonists

- glucocorticoid receptor antagonists

- GAT-1 inhibitors

- calcium channel blockers Calcium Channel Blockers Definition

Calcium channel blockers are medicines that slow the movement of calcium into the cells of the heart and blood vessels.
 

- compounds with unknown mechanism of action

- drugs in development

ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS

Neurobiological Aspects of ADHD Attention-Deficit/Hyperactivity Disorder (ADHD) Definition

Attention-deficit/hyperactivity disorder (ADHD) is a developmental disorder characterized by distractibility, hyperactivity, impulsive behaviors, and the inability to remain focused on tasks or
 

Clinical and Therapeutical Facts

Pharmacology

Marketed Drugs and Drugs in Development

GLOSSARY

For more information visit http://www.researchandmarkets.com/reports/c53029
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 29, 2007
Words:424
Previous Article:SpectRx, Inc. Elects New Directors.
Next Article:Broadcasting Media Partners Completes Acquisition of Univision.



Related Articles
Schizophrenia, depression share brain clue.
The Role of Medications in the Employment of People with Schizophrenia.
Placebos for depression attract scrutiny.
Psychiatric manifestations of medications commonly prescribed in otolaryngology.
Blackwell acquires two journals from Neva Press.
Blackwell acquires two journals from Neva Press.
The other side of psychopharmacology: a review of the literature.
Workgroup report: review of genomics data based on experience with mock submissions--view of the CDER pharmacology toxicology Nonclinical...
Bipolar surprise: mood disorder endures antidepressant setback.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles